Bulletin 2010/35 - European Patent Office
28.12.2012 • Views
Share Embed Flag

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(C07D) II.1(1)<br />

TAKEMOTO, Masaki Mitsubishi Gas Chemical<br />

Co., Inc., Shinwari, Niigata-shi Niigata<br />

9503112, JP<br />

NAKANO, Rieko c/o Mitsubishi Gas Chemical<br />

Co., Inc, Shinwari, Niigata-shi Niigata<br />

9503112, JP<br />

(74) Harrison, Robert John, et al, 24IP Law Group<br />

Sonnenberg Fortmann <strong>Patent</strong>- & Rechtsanwälte<br />

Postfach 33 08 65, 80068 München,<br />

DE<br />

C07D 303/16 → (51) C07D 301/12<br />

(51) C07D 305/12 (11) 1 751 126 B1<br />

A61K 31/3<strong>35</strong> A61P 3/00<br />

(25) De (26) De<br />

(21) 05716736.3 (22) 18.02.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(43) 14.02.2007<br />

(86) EP 2005/050719 18.02.2005<br />

(87) WO 2005/080366 2005/<strong>35</strong> 01.09.2005<br />

(30) 23.02.2004 DE 102004009076<br />

(54) • ALKYLCARBAMAT-SUBSTITUIERTE<br />

BUTYROLACTONE ALS LIPASE-INHIBITO-<br />

REN<br />

• ALKYL CARBAMATE-SUBSTITUTED<br />

BUTYROLACTONES SERVING AS LIPASE<br />

INHIBITORS<br />

• BUTYROLACTONES SUBSTITUEES PAR<br />

CARBAMATE D'ALKYLE, UTILISEES<br />

COMME INHIBITEURS DE LIPASE<br />

(73) Abbott Products GmbH, Hans-Böckler-Allee<br />

20, 30173 Hannover, DE<br />

(72) WALDECK, Harald, 30916 Isernhagen, DE<br />

ANTEL, Jochen, 31848 Bad Münder, DE<br />

EYTING, Sabine, 48159 Münster, DE<br />

WURL, Michael, 30826 Garbsen, DE<br />

GREGORY, Peter-Colin, 30559 Hannover, DE<br />

WOLFF, Maike, 30171 Hannover, DE<br />

(74) Gosmann, Martin, et al, Abbott Products<br />

GmbH IP Department (PH-ZP), Hans-Böckler-Allee<br />

20 30173 Hannover, DE<br />

C07D 307/20 → (51) C07D 319/06<br />

C07D 309/12 → (51) C07D 319/06<br />

(51) C07D 309/30 (11) 1 555 261 B1<br />

A61K 8/36 A61Q 13/00<br />

C11B 9/00 A23L 1/226<br />

A23L 2/00<br />

(25) Ja (26) En<br />

(21) 03753957.4 (22) 26.09.2003<br />

(84) CH DE ES FR GB LI<br />

(43) 20.07.2005<br />

(86) JP 2003/012341 26.09.2003<br />

(87) WO 2004/029033 2004/15 08.04.2004<br />

(30) 27.09.2002 JP 2002282675<br />

23.10.2002 JP 2002308952<br />

16.09.2003 JP 2003323125<br />

(54) • VALEROLACTONVERBINDUNGEN UND<br />

PARF MZUSAMMENSETZUNG<br />

• VALEROLACTONE COMPOUNDS AND<br />

PERFUME COMPOSITION<br />

• COMPOSES DE VALEROLACTONE ET<br />

COMPOSITION DE PARFUM<br />

(73) KAO CORPORATION, 14-10, Nihonbashi<br />

Kayaba-cho 1-chome, Chuo-ku, Tokyo 103-<br />

8210, JP<br />

(72) Tanaka, Sakuya, Wakayama-shi, Wakayama<br />

640-8580, JP<br />

Fukuda, Kazuyuki, Sumida-ku, Tokyo 131-<br />

8501, JP<br />

Asada, Takahiro, Wakayama-shi, Wakayama<br />

640-8580, JP<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastrasse 4, 81925 München, DE<br />

(51) C07D 311/08 (11) 2 019 825 B1<br />

A61K 31/<strong>35</strong>2 A61K 31/47<br />

A61P 31/18 C07D 215/22<br />

C07D 215/14 C07D 215/18<br />

C07D 311/12 C07D 311/14<br />

C07D 401/04 C07D 401/12<br />

C07D 405/04 C07D 409/04<br />

C07D 413/12 C07D 215/227<br />

(25) En (26) En<br />

(21) 07784947.9 (22) 14.05.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

BA HR RS<br />

(43) 04.02.2009<br />

(86) CA 2007/000845 14.05.2007<br />

(87) WO 2007/131<strong>35</strong>0 2007/47 22.11.2007<br />

(30) 16.05.2006 US 747311 P<br />

(54) • HEMMER DER NEUBILDUNG MENSCH-<br />

LICHER IMMUNDEFEKT-VIREN<br />

• INHIBITORS OF HUMAN IMMUNODEFI-<br />

CIENCY VIRUS REPLICATION<br />

• INHIBITEURS DE LA RÉPLICATION DU<br />

VIRUS DE L'IMMUNODÉFICIENCE<br />

HUMAINE<br />

(73) Boehringer Ingelheim International GmbH,<br />

Binger Strasse 173, 55216 Ingelheim, DE<br />

(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR<br />

HU IE IS IT LI LT LU LV MC MT NL PL PT RO<br />

SE SI SK TR<br />

(73) Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Strasse 173, 55216 Ingelheim,<br />

DE<br />

(84) DE<br />

(72) TSANTRIZOS, Youla, S., Laval, Quebec H7S<br />

2G5, CA<br />

BOES, Michael, 80796 Munich, DE<br />

BROCHU, Christian, Laval, Québec H7S 2G5,<br />

CA<br />

FENWICK, Craig, Laval, Québec H7S 2G5, CA<br />

MALENFANT, Eric, Laval, Québec H7S 2G5,<br />

CA<br />

MASON, Stephen, Laval, Québec H7S 2G5,<br />

CA<br />

PESANT, Marc, Laval, Québec H7S 2G5, CA<br />

(74) Hammann, Heinz, Boehringer Ingelheim<br />

GmbH CD-<strong>Patent</strong>s Binger Straße 173, 55216<br />

Ingelheim am Rhein, DE<br />

C07D 311/12 → (51) C07D 311/08<br />

C07D 311/14 → (51) C07D 311/08<br />

C07D 317/24 → (51) C07D 319/06<br />

(51) C07D 319/06 (11) 1 637 528 B1<br />

C07D 317/24 C07D 309/12<br />

C07D 307/20 C07D 493/04<br />

A61K 31/<strong>35</strong> A61P 31/12<br />

(25) En (26) En<br />

(21) 05028389.4 (22) 18.04.1996<br />

(84) AT BE CH DE DK ES FI FR GB GR IE IT LI LU<br />

MC NL PT SE<br />

AL LT LV SI<br />

(43) 22.03.2006<br />

(30) 19.04.1995 US 424810<br />

(54) • Sulfonamide, die einen sauerstoffhaltigen<br />

Heterozyklus enthalten als Inhibitoren von<br />

Aspartyl-Protease<br />

• Oxygenated-heterocycle containing sulfonamide<br />

inhibitors of aspartyl protease<br />

• Sufamides contenant des hétérocycles<br />

oxygénés et agissant comme inhibiteurs de<br />

l'aspartyle protéase<br />

585<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>35</strong>/<strong>2010</strong>) 01.09.<strong>2010</strong><br />

(73) VERTEX PHARMACEUTICALS INCORPO-<br />

RATED, 130 Waverly Street, Cambridge, MA<br />

02139-4242, US<br />

(72) Tung, Roger D., San Diego, CA 92130, US<br />

Bhisetti, Govinda Rao, Lexington MA 02421,<br />

US<br />

(74) Vossius & Partner, Siebertstrasse 4, 81675<br />

München, DE<br />

(62) 0111<strong>35</strong>75.3 / 1 136 479<br />

96913811.4 / 0 833 826<br />

C07D 333/16 → (51) C12P 17/16<br />

C07D 333/20 → (51) C12P 17/16<br />

C07D 333/34 → (51) C07D 213/71<br />

C07D 333/36 → (51) C07C 323/42<br />

C07D 333/36 → (51) C07D 409/12<br />

C07D 333/48 → (51) C07C 323/42<br />

C07D 3<strong>35</strong>/02 → (51) C07C 323/42<br />

(51) C07D 401/04 (11) 1 607 394 B1<br />

(25) Zh (26) En<br />

(21) 04717008.9 (22) 04.03.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

(43) 21.12.2005<br />

(86) CN 2004/000167 04.03.2004<br />

(87) WO 2004/085422 2004/41 07.10.2004<br />

(30) 27.03.2003 CN 03120994<br />

(54) • WASSERLÖSLICHE THALIDOMINDERI-<br />

VATE<br />

• WATER-SOLUBLE THALIDOMINE DERI-<br />

VATIVES<br />

• DERIVES DE THALIDOMIDE HYDROSO-<br />

LUBLE<br />

(73) Tian Jin Hemay Bio-Tech Co., Ltd., Xiao<br />

Yuan Xin Cun 31-101 Teda, Tianjin 300457,<br />

CN<br />

(72) ZHANG, Hesheng, Tianjin, 300457, CN<br />

(74) Stuttard, Garry Philip, Urquhart-Dykes &<br />

Lord LLP Tower North Central Merrion Way,<br />

Leeds LS2 8PA, GB<br />

C07D 401/04 → (51) C07D 311/08<br />

C07D 401/04 → (51) C07D 401/14<br />

C07D 401/06 → (51) A61K 31/167<br />

C07D 401/06 → (51) A61K 31/496<br />

(51) C07D 401/12 (11) 1 856 096 B1<br />

C07D 207/14 A61K 31/4725<br />

A61K 31/40<br />

(25) En (26) En<br />

(21) 067177<strong>35</strong>.2 (22) 09.01.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 21.11.2007<br />

(86) US 2006/000571 09.01.2006<br />

(87) WO 2006/076246 2006/29 20.07.2006<br />

(30) 10.01.2005 US 642751 P<br />

(54) • ALS ANTIKOAGULANZIEN VERWENDBARE<br />

PHENYLGLYCINAMID-DERIVATE<br />

• PHENYLGLYCINAMIDE DERIVATIVES<br />

USEFUL AS ANTICOAGULANTS<br />

• DERIVES DE PHENYLGLYCINAMIDE UTI-<br />

LISES COMME ANTICOAGULANTS<br />

(73) Bristol-Myers Squibb Company, Route 206<br />

and Province Line Road, Princeton NJ<br />

08543-4000, US

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!